HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preserved gastric tonometric variables in cardiac surgical patients administered intravenous perflubron emulsion.

AbstractUNLABELLED:
Low gastric intramucosal pH (pHi) and an increased gastric-arterial PCO2 difference (CO2 gap) are markers of tissue hypoperfusion. Perfluorocarbons (PFCs) have a large oxygen-carrying capacity and release oxygen when encountering low tissue oxygen tension. Nine cardiac surgical patients instrumented for gastric tonometry were enrolled as part of a multicenter, randomized, single-blinded study of a PFC emulsion (perflubron emulsion [Oxygent]). Patients were randomized to receive PFC (n = 4) or placebo (n = 5) after intraoperative autologous blood harvesting by acute normovolemic hemodilution. At baseline there were no intergroup differences in tonometric-, hemodynamic-, or oxygen delivery-derived variables, e.g., Control group (pHi, 7.37 +/- 0.06; CO2 gap, 6.4 +/- 1.3 mm Hg) versus PFC group (pHi, 7.38 +/- 0.06; CO2 gap, 6.7 +/- 1.5 mm Hg). After acute normovolemic hemodilution, pHi was significantly lower (P < 0.01) in the Control group (7.22 +/- 0.25) than in the PFC group (7.44 +/- 0.25), and CO2 gap was significantly higher (P < 0.001) in the Control group (23.4 +/- 5.1 mm Hg) than in the PFC group (1.8 +/- 0.8 mm Hg). These differences in tonometric variables persisted during surgery. The PFC group showed a significantly (P < 0.007) shorter time to first bowel movement postoperatively (2.0 +/- 0.8 vs 5.4 +/- 1.6 days). Time to consumption of solid food was also shorter in the PFC group and almost achieved statistical significance (P = 0.056).
IMPLICATIONS:
This study suggests that the administration of perflubron emulsion prevents gastrointestinal tract ischemia in cardiac surgical patients and may preserve postoperative gastrointestinal tract function.
AuthorsRobert J Frumento, Linda Mongero, Yoshifumi Naka, Elliott Bennett-Guerrero
JournalAnesthesia and analgesia (Anesth Analg) Vol. 94 Issue 4 Pg. 809-14, table of contents (Apr 2002) ISSN: 0003-2999 [Print] United States
PMID11916777 (Publication Type: Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • Emulsions
  • Fluorocarbons
  • Hemoglobins
  • Hydrocarbons, Brominated
  • Carbon Dioxide
  • perflubron
  • Oxygen
Topics
  • Aged
  • Blood Transfusion, Autologous
  • Carbon Dioxide (blood, metabolism)
  • Cardiopulmonary Bypass
  • Coronary Artery Bypass
  • Emulsions
  • Fluorocarbons (administration & dosage)
  • Gastric Mucosa (blood supply, metabolism)
  • Hemodilution
  • Hemoglobins (analysis)
  • Humans
  • Hydrocarbons, Brominated
  • Hydrogen-Ion Concentration
  • Infusions, Intravenous
  • Middle Aged
  • Oxygen (blood)
  • Oxygen Consumption
  • Partial Pressure
  • Single-Blind Method

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: